CureAge Therapeutics
PrivateLast Round
Grant
Jul 16, 2026
Total Funding Raised
$670,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CureAge Therapeutics is a biotechnology company that develops genetic therapies using lipid nanoparticle delivery systems to treat neurofibromatosis type 1 and other peripheral nerve disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureAge Therapeutics Comparables
Compare CureAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rubedo Life Sciences | 84% | |
| Turn Biotechnologies | 79% | |
| Retro Biosciences | 76% |
CureAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2026 | ||||
| Pre Seed | Jan 1, 2025 |
Key People
Founding team and executive leadership
CureAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Grant, Pre Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jul 16, 2026
$670K raised from Deep Science Ventures and others.
CureAge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CureAge Therapeutics's valuation, stock price, and market status.
Is CureAge Therapeutics a public or private company?
CureAge Therapeutics is a private company.
What is the current stock price of CureAge Therapeutics?
CureAge Therapeutics is a private company with no public stock price. Caplight tracks CureAge Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CureAge Therapeutics worth (valuation)?
Valuation information for CureAge Therapeutics is not publicly available.
Can I buy CureAge Therapeutics stock?
CureAge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CureAge Therapeutics's last funding round?
CureAge Therapeutics's most recent funding round was Grant on July 16, 2026.
Who are the main investors in CureAge Therapeutics?
Key investors in CureAge Therapeutics include Deep Science Ventures, Innovate UK.
Will CureAge Therapeutics IPO soon?
No public IPO plans have been announced for CureAge Therapeutics.
How can I track CureAge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureAge Therapeutics's secondary market activity and sign up for updates.